Pharmacy

Your Article Summary

See Latest Articles

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
BioMarin, 07/31/09

BioMarin Pharmaceutical Inc. announced that the United States Patent Office has issued patents covering stable tablet formulation and the approved once daily dosing regimen for Kuvan for the treatment of phenylketonuria. The patent for stable tablet formulation expires in 2025, and the patent for the once daily dosing regimen expires in 2024.

Today in Dosing...keeping you current

Receive free subspecialty "5-minute updates" via email

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

See All of Dosing

Today in Drug Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

See All of Drug Approvals

Today in Drug/Product Alerts...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09

See All of Drug/Product Alerts